New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic
Coronavirus COVID-19 (official nomenclature SARS-CoV-2), has, since March 2020 when the WHO announced its pandemic nature, created major challenges in the world, causing a public health crises with severe economic consequences. A crucial element of this highly contagious virus is its capability to propagate exponentially into susceptible hosts, often causing severe inflammatory thrombotic microcirculatory events leading to multiorgan dysfunction and emergency hospitalisations, causing chaos in healthcare systems.
Source: Transfusion and Apheresis Science - Category: Hematology Authors: Jerard Seghatchian Tags: Editorial Source Type: research
More News: Coronavirus | COVID-19 | Emergency Medicine | Hematology | International Medicine & Public Health | Pandemics | SARS | Science | Vaccines